Keywords: AR; androgen receptor; DHT; Dihydrotestosterone; T; testosterone; BPH; benign prostatic hyperplasia; PAT; potassium antimony tartrate; PTH; potassium tartrate hemihydrate; qRT-PCR; quantitative real-time polymerase chain reaction; Abs; antibodies; Cas; bi
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Urolithins; Prostate cancer; Interactions; Ellagitannins gut metabolites; ADT; androgen deprivation therapy; AR; androgen receptor; bic; bicalutamide; CI; combination index; DHT; dihydrotestosterone; GnRH; gonadotropin-releasing hormone; PSA; prostate spe
Keywords: Androgen receptor; Bicalutamide; Castration resistant prostate cancer; Estrogen receptor; Prostate; Raloxifene;
Keywords: Triple negative breast cancer; Androgen receptor; Bicalutamide; Enzalutamide; Abiraterone acetate; Seviteronel;
Keywords: Bicalutamide; Enzalutamide; Prostate cancer; Perfluoroalkyl; Androgen receptor; Antiproliferative activity;
Keywords: Prostate cancer cells; PC-3 and LNCaP; Mononuclear cells; LHRH agonist; Leuprolide; Bicalutamide; Inflammatory cytokines
Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress
Keywords: Bicalutamide; Macrogol 6000; Poloxamer 407; Dissolution; Solid dispersion; Planetary ball milling;
Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial
Keywords: Bicalutamide; Enzalutamide; Metastatic castration-resistant prostate cancer; Quality of life;
Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS
Keywords: Bicalutamide; Enzalutamide; Abiraterone; Tandem mass spectrometry; Metabolites; Assay; Validation;
Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway
Keywords: Prostate cancer; T877A; Androgen receptor antagonist; Bicalutamide; LNCaP; Apoptosis; AR; Androgen receptor; DHT; Dihydrotestosterone; AIPC; Androgen Independent Prostate Cancer; LBD; Ligand Binding Domain; R-BIC; R-Bicalutamide; ETS; Erythroblast Transfo
Improving the physicochemical properties of bicalutamide by complex formation with bovine serum albumin
Keywords: Bovine serum albumin; Bicalutamide; Anti-solvent precipitation; Interaction; Molecular docking;
Analytical and semipreparative high performance liquid chromatography enantioseparation of bicalutamide and its chiral impurities on an immobilized polysaccharide-based chiral stationary phase
Keywords: Enantiomers; Chiralpak IA; Bicalutamide; Impurities; Temperature-variable HPLC; Semipreparative resolution
Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer
Keywords: Prostate; Cytoreduction; Brachytherapy; Dutasteride; Bicalutamide
Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth
Keywords: Androgen receptor; Bicalutamide; Bladder cancer; Enzalutamide; Flutamide;
Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans
Keywords: Bicalutamide; Prostate cancer; ABCB1; P-glycoprotein; BCRP; ABCG2;
Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells
Keywords: miRNA; microRNA; AR; androgen receptor; BIC; bicalutamide; DHT; dihydrotestosterone; MIB; mibolerone; PSA; prostate-specific antigen; AREs; androgen responsive elements; VEGF; vascular endothelial growth factor; EGF; epithelial growth factor; Androgen ago
Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact?
Keywords: Prostate cancer; Antiandrogen; Bicalutamide; Flutamide; Nilutamide; LHRH agonist; Flare;
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study
Keywords: Antiandrogen; Bicalutamide; Localised; Locally advanced; Prostate cancer; Survival;
A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer
Keywords: Castration-resistant prostate cancer (CRPC); Dutasteride; Bicalutamide; Prostate-specific antigen (PSA); Androgen deprivation therapy (ADT);
Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide
Keywords: Triazole; Click chemistry; Androgen receptor; Molecular modeling; Bicalutamide; Prostate cancer;
Testosterone enhances cardiomyogenesis in stem cells and recruits the androgen receptor to the MEF2C and HCN4 genes
Keywords: mES; mouse embryonic stem cells; AR; androgen receptor; EB; embryoid body; EC; embryonal carcinoma; HCN4; hyperpolarization activated cyclic nucleotide-gated potassium channel-4; MEF2C; myocyte enhancer factor 2C; AREs; androgen response elements; Fin; fi
Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: Physicochemical investigations
Keywords: Nanostructured lipid carrier; Bicalutamide; Poorly water-soluble; High-pressure homogenization; Crystalline Form I; Raman analysis
Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation
Keywords: Prostate cancer; Antiandrogen resistance; Bicalutamide; Endothelial nitric oxide synthase; Nitric oxide; Androgen receptor
A comparative assessment of α-lipoic acid N-phenylamides as non-steroidal androgen receptor antagonists both on and off gold nanoparticles
Keywords: Androgen receptor; α-Lipoic acid; Flutamide; Bicalutamide; Prostate cancer;
Neoadjuvant Hormone Therapy for Radical Prostate Radiotherapy: Bicalutamide Monotherapy vs. Luteinizing Hormone–Releasing Hormone Agonist Monotherapy: A Single-Institution Matched-Pair Analysis
Keywords: Bicalutamide; LHRHa; Neoadjuvant hormone; Prostate Cancer; Radiotherapy
A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia
Keywords: Antiandrogen; Bicalutamide; Breast pain; Gynecomastia; Prostate cancer
Steroid derivatives as pure antagonists of the androgen receptor
Keywords: GnRH, gonadotropin-releasing hormoneProstate cancer; Antiandrogen; Androgen receptor; Androgen blockade; Bicalutamide; MDV3100
Pharmaceutical NanotechnologyFormation of bicalutamide nanodispersion for dissolution rate enhancement
Keywords: Bicalutamide; Hydrophilic excipients; Nanodispersion; In vitro dissolution;
Synthesis and biological activity of ferrocenyl derivatives of the non-steroidal antiandrogens flutamide and bicalutamide
Keywords: Anticancer agents; Antiandrogen; Ferrocene; Prostate cancer; Flutamide; Bicalutamide
Is Prophylactic Breast Radiotherapy Necessary in All Patients With Prostate Cancer and Gynecomastia and/or Breast Pain?
Keywords: prostate; prostatic neoplasms; gynecomastia; bicalutamide; radiotherapy; PRT; prophylactic RT; RT; radiation therapy;
Relative Bioavailability and Tolerability of Two Formulations of Bicalutamide 50-mg Tablets: A Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Korean Male Subjects
Keywords: bicalutamide; bioequivalence; healthy subjects; pharmacokinetic
An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients
Keywords: Gynaecomastia; Mastalgia; Sexual functioning; Prostate cancer; Tamoxifen; Bicalutamide
Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-l-lactide) block copolymers for drug delivery
Keywords: Micelles; Copolymer; Polyethylene glycol; Polycarbonate; Poly lactic acid; Bicalutamide
Physicochemical Characterization of Hot Melt Extruded Bicalutamide-Polyvinylpyrrolidone Solid Dispersions
Keywords: hot melt extrusion; solid dispersions; bicalutamide;
High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats
Keywords: Column liquid chromatography; Bicalutamide; Pharmacokinetic study; Self micro-emulsifying drug delivery (SMEDDS)
Nanosized bicalutamide and its molecular structure in solvents
Keywords: Bicalutamide; Nanoparticles; Anti-solvent precipitation; Conformers; Solvent effects
Pathological Effects of Prostate Cancer Correlate With Neuroendocrine Differentiation and PTEN Expression After Bicalutamide Monotherapy
Keywords: prostatic neoplasms; treatment failure; bicalutamide; PTEN phosphohydrolase; epidermal growth factor; ADT; androgen deprivation therapy; BCR; biochemical recurrence; CgA; chromogranin A; ECE; extracapsular extension; HER; human epidermal receptor; IHC; im
Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity
Keywords: ALT; alanine aminotransferase; BIC; bicalutamide; DILI; drug-induced liver injury; FLU; flutamide; OXPHOS; oxidative phosphorylation; ROS; reactive oxygen species; SOD2; superoxide dismutase-2 (Mn-SOD); TUNEL; terminal deoxynucleotidyl transferase-mediate
Bicalutamide failure in prostate cancer treatment: Involvement of Multi Drug Resistance proteins
Keywords: Bicalutamide; Calcein-AM; P-glycoprotein; BCRP; MRP1
Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity
Keywords: Bicalutamide; Brachytherapy; Prostate cancer; Volume reduction
Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations
Keywords: Nuclear receptor; Androgen receptor; Molecular dynamics; Passive antagonism; Prostate cancer; Flutamide; Bicalutamide
Polymorph Transitions of Bicalutamide: A Remarkable Example of Mechanical Activation
Keywords: bicalutamide; amorphous phase; polymorph transition; mechanical activation; calorimetry (DSC); hot-stage X-ray diffractometry; hot-stage microscopy;
Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study
Keywords: Bicalutamide; Forced degradation; Process impurities; Kinetics of degradation; Isolation and characterization
2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists
Keywords: Benzimidazoles; Androgen receptor antagonists; Bicalutamide
Bacillus subtilis epoxide hydrolase-catalyzed preparation of enantiopure 2-methylpropane-1,2,3-triol monobenzyl ether and its application to expeditious synthesis of (R)-bicalutamide
Keywords: Epoxide hydrolase; (R)-1-Benzyloxy-2-methylpropane-2,3-diol; Kinetic resolution; Diol; Bicalutamide;
Conformational polymorphism in bicalutamide
Keywords: Bicalutamide; Polymorphism; Stability; Crystal structure; Thermal analysis
Estrogen and androgen repression of two female specific lacrimal lipocalins in hamster: Pituitary independent and sex hormone receptor mediated action
Keywords: Flutamide; Bicalutamide; Cyproterone acetate; Tamoxifen; Raloxifene; ICI-182780; Syrian hamster; Harderian gland; Dry eye
Antiandrogens in the Treatment of Prostate Cancer
Keywords: Prostate cancer; Hormonal treatment; Antiandrogens; Bicalutamide; Flutamide; Nilutamide; Cyproterone acetate
Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150 mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose–Response Study
Keywords: Bicalutamide; Breast pain; Gynaecomastia; Management; Nonsteroidal antiandrogen; Prophylaxis; Prostate cancer; Tamoxifen
Antiandrogen therapy in prostate cancer
Keywords: Antiandrogen; Prostate cancer; Bicalutamide; Flutamide; Nilutamide